# electroCore to Announce Fourth Quarter and Full Year Ended December 31, 2025, Financial Results on Thursday, March 19, 2026
Canonical URL: https://biopharmsignal.com/news/ECOR/electrocore-to-announce-fourth-quarter-and-full-year-ended-december-31-2025-fina-c6f97ade
Ticker: ECOR
Company: electroCore
Source: electroCore
Published: 2026-03-09 12:00 EST
## Summary

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company,...

## Article Body
electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will report financial results for the fourth quarter and full year ended December 31, 2025, after the close of the market on Thursday, March 19, 2026.

Management will host a webinar at 4:30 PM EDT to review the financial results and answer questions. Investors can access the webinar using the details below:

Thursday, March 19, 4:30 PM EDT Dial-In: (646) 931-3860 Webinar ID: 886 9421 4883 Passcode: 014212 Registration Link: Click here to participate and ask questions on the call.

About electroCore, Inc. electroCore, Inc. and its subsidiaries (“electroCore” or the “Company”) is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products to treat chronic pain syndromes through non-invasive neuromodulation technology are gammaCore non-invasive vagus nerve stimulation, or nVNS, and the Quell® Fibromyalgia. Additionally, the Company commercializes its handheld and personal use Truvaga and TAC-STIM nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com .

Contact ECOR Investor Relations (973) 302-9253 investors@electrocore.com
## Recent Company News
- 2026-07-16 12:00 EST — [New Review Examines Anatomical and Methodological Differences Between Auricular and Cervical Vagus Nerve Stimulation](https://biopharmsignal.com/news/ECOR/new-review-examines-anatomical-and-methodological-differences-between-auricular--75858401) — Source: electroCore
- 2026-06-17 12:00 EST — [electroCore to Participate in iAccess Alpha Virtual Best Ideas Summer Investment Conference](https://biopharmsignal.com/news/ECOR/electrocore-to-participate-in-iaccess-alpha-virtual-best-ideas-summer-investment-07437969) — Source: electroCore
- 2026-06-09 12:00 EST — [Frontiers in Neuroscience Accepts Review Article Synthesizing Evidence that Cervical nVNS Activates the Vagus Nerve Without Surgery](https://biopharmsignal.com/news/ECOR/frontiers-in-neuroscience-accepts-review-article-synthesizing-evidence-that-cerv-90a5568d) — Source: electroCore
- 2026-06-02 12:00 EST — [electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub](https://biopharmsignal.com/news/ECOR/electrocore-to-present-at-the-planet-microcap-las-vegas-2026-powered-by-microcap-9774a6c0) — Source: electroCore
- 2026-05-13 12:00 EST — [electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia](https://biopharmsignal.com/news/ECOR/electrocore-announces-publication-in-jama-highlighting-the-benefits-of-adding-qu-c4813dca) — Source: electroCore
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)